Skip to main content
Scott Millman, MD, Oncology, New York, NY

ScottEMillmanMDPhD

Oncology New York, NY

Hematologic Oncology

Physician

Overview of Dr. Millman

Dr. Scott Millman is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and Memorial Sloan Kettering Cancer Center. He received his medical degree from New York University Grossman School of Medicine and has been in practice 4 years. He is one of 497 doctors at Memorial Sloan Kettering Cancer Center and one of 497 doctors at Memorial Sloan Kettering Cancer Center who specialize in Oncology. He has 7 publications and over 200 citings.

Education & Training

  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2016 - 2020
  • Massachusetts General Hospital
    Massachusetts General HospitalResidency, Internal Medicine, 2014 - 2017
  • New York University School of Medicine
    New York University School of MedicineClass of 2014

Certifications & Licensure

  • NJ State Medical License
    NJ State Medical License 2021 - 2025
  • NY State Medical License
    NY State Medical License 2016 - 2025
  • MA State Medical License
    MA State Medical License 2014 - 2016
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Abstracts/Posters

  • Annotation of Somatic Genomic Variants in Hematologic Diseases Using OncoKB, a Precision Oncology Knowledgebase
    Scott Millman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Press Mentions

  • New Clinical Practice Guidelines for Von Willebrand Disease, Announcing the 2021 ASH Scholar Award Recipients, and More
    New Clinical Practice Guidelines for Von Willebrand Disease, Announcing the 2021 ASH Scholar Award Recipients, and MoreFebruary 1st, 2021
  • Memorial Sloan Kettering Awards & Appointments
    Memorial Sloan Kettering Awards & AppointmentsJanuary 25th, 2021